Banco Santander (SAN)
(Real Time Quote from BATS)
$4.72 USD
+0.08 (1.72%)
Updated Nov 14, 2024 12:24 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SAN 4.72 +0.08(1.72%)
Will SAN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for SAN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SAN
Is Hartford Multifactor Developed Markets (ex-US) ETF (RODM) a Strong ETF Right Now?
BNY Mellon Receives SEC's Approval to Offer ETF Crypto Custody Service
SAN: What are Zacks experts saying now?
Zacks Private Portfolio Services
BlackRock Expands Further Into Private Assets, Partners With Santander
SAN or NABZY: Which Is the Better Value Stock Right Now?
Banco Santander (SAN) Upgraded to Buy: Here's What You Should Know
Other News for SAN
Biotech Alert: Searches spiking for these stocks today
Banco Santander Advances in Share Buyback Programme
Dodge & Cox International Stock Fund Q3 2024 Shareholder Letter
Sanofi treatment of acute myeloid leukemia granted orphan status
Banco Santander Executive’s Strategic Stock Transactions